REGENERON PHARMACEUTICALS, INC.: revenue
| Value | {"amount": 16071700000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2ca7c48b-2097-49eb-ad5c-4d5bdead19b5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001804220-22-000007Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/revenue/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2ca7c48b-2097-49eb-ad5c-4d5bdead19b5
History
- no predecessors — first report